Routine Histoprognostic Factors in Early-Stage Breast Carcinoma: A Review

References

• NIH Consensus Development Panel. Treatment of early-stage breast cancer. JAMA 1991; 265: 391–395
   PubMed Web of Science ®Google Scholar
• Stoll B A. Prognostic indices in breast cancer. Dev Oncol 1987; 48: 195–229
   Google Scholar
• McGuire W L, Tandon A K, Allred D C. How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 1990; 82: 1006–1015
   PubMed Web of Science ®Google Scholar
• Page D L. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol 1991; 15: 334–349
   PubMed Web of Science ®Google Scholar
• Menck H R, Garfinkel L, Dodd G D. Preliminary report of the National Cancer Data Base. CA-A Cancer J for Clinicians 1991; 41: 7–18
   PubMed Web of Science ®Google Scholar
• Beahrs O H, Henson D E, Hutter R VP. Manual for Staging of Cancer, 3rd ed. Lippincott, Philadelphia 1988; 146–147
   Google Scholar
• Clark G M, McGuire W L. New biologic prognostic factors in breast cancer. Oncology 1989; 3: 49–54
   PubMedGoogle Scholar
• Elston C W, Ellis I O. Pathology and breast screening. Histopath-ology 1990; 16: 109–118
   PubMed Web of Science ®Google Scholar
• Page D L, Anderson T J, Connolly J L. Miscellaneous features of carcinoma. Diagnostic Histopathology of the Breast, DL Page, TJ Anderson. Churchill Livingstone, Edinburgh 1987; 278–279
   Google Scholar
• Fechner R E, Mills S E. Breast Pathology. Benign Proliferations. Atypias and In Situ Carcinomas. ASCP Press, Chicago 1990; 114
   Google Scholar
• Rosner D, Lane W W, Penetrante R. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 1991; 67: 1498–1503
   PubMed Web of Science ®Google Scholar
• Schnitt S J, Silen W, Sadowsky N L. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988; 318: 898–903
   PubMed Web of Science ®Google Scholar
• VanDongen J A, Harris J R, Peterse J L. In-situ breast cancer: the EORTC consensus meeting. Lancet 1989; 2: 25–26
   PubMed Web of Science ®Google Scholar
• Patchefsky A S, Schwartz G F, Finkelstein S D. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63: 731–741
   PubMed Web of Science ®Google Scholar
• Schnitt S J, Connolly J L, Khettry U. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 1987; 59: 675–681
   PubMed Web of Science ®Google Scholar
• Lagios M D. Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 1990; 70: 853–871
   PubMed Web of Science ®Google Scholar
• Jacquemier J, Kurtz J M, Amalric R. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer 1990; 61: 873–876
   PubMed Web of Science ®Google Scholar
• Swain S M. Noninvasive breast cancer. Part I. Ductal carcinoma in situ–incidence, presentation, guidelines to treatment. Oncology 1989; 3: 25–31
   PubMedGoogle Scholar
• Swain S M. Noninvasive breast cancer. Part 2. Lobular carcinoma in situ–incidence, presentation, guidelines to treatment. Oncology 1989; 3: 35–40
   PubMedGoogle Scholar
• Fisher E R, Kenny J P, Sass R. Medullary carcinoma of the breast revisited. Breast Cancer Res Treat 1990; 16: 215–229
   PubMed Web of Science ®Google Scholar
• Pedersen L, Zedler K, Hoick S. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Br J Cancer 1991; 63: 591–595
   PubMed Web of Science ®Google Scholar
• Anderson T J, Lamb J, Donnan P. Comparative pathology of breast cancer in a randomized trial of screening. Br J Cancer 1991; 64: 108–113
   PubMed Web of Science ®Google Scholar
• Page D L, Anderson T J, Sakamoto G. Infiltrating carcinoma: major histological types. Diagnostic Histopathology of the Breast, DL Page, TJ Anderson. Churchill Livingstone, Edinburgh 1987; 193–235
   Google Scholar
• DiConstanzo D, Rosen P P, Garen I. Prognosis in infiltrating lobular carcinoma. An analysis of “classical” and variant tumors. Am J Surg Pathol 1990; 14: 12–23
   PubMed Web of Science ®Google Scholar
• DuToit R S, Locker A P, Ellis I O. Invasive lobular carcinomas of the breast–the prognosis of histopathological subtypes. Br J Cancer 1989; 60: 605–609
   PubMed Web of Science ®Google Scholar
• Venable J G, Schwartz A M, Silverberg S G. Infiltrating cribriform carcinoma of the breast. A distinctive clinicopathologic entity. Hum Pathol 1990; 21: 333–338
   PubMed Web of Science ®Google Scholar
• Carter C L, Allen C, Henson D E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–187
   PubMed Web of Science ®Google Scholar
• Ciatto S, Cecchini S, Grazzini G. Tumor size and prognosis of breast cancer with negative axillary nodes. Neoplasma 1990; 37: 179–184
   PubMed Web of Science ®Google Scholar
• O'Reilly S M, Camplejohn R S, Barnes D M. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol 1990; 8: 2040–2046
   PubMed Web of Science ®Google Scholar
• Rosen P P, Groshen S. Factors influencing survival and prognosis in early breast carcinoma. Surg Clin North Am 1990; 70: 937–962
   PubMed Web of Science ®Google Scholar
• Rosner D, Lane W W. Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy. Cancer 1990; 66: 199–205
   PubMed Web of Science ®Google Scholar
• Eberlein T J, Connolly J L, Schnitt S J. Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg 1990; 125: 771–775
   PubMed Web of Science ®Google Scholar
• Todd J H, Dowle C, Williams M R. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987; 56: 489–492
   PubMed Web of Science ®Google Scholar
• Van Diest P J, Baak J P. The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 1991; 22: 326–330
   PubMed Web of Science ®Google Scholar
• Quinn C M, Wright N A. The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables. J Pathol 1990; 160: 93–102
   PubMed Web of Science ®Google Scholar
• Contesso G, Mouriesse H, Friedman S. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 1987; 5: 1378–1386
   PubMed Web of Science ®Google Scholar
• Elston C W. Grading of invasive carcinoma of the breast. Diagnostic Histopathology of the Breast, DL Page, TJ Anderson. Churchill Livingstone, Edinburgh 1987; 300–311
   Google Scholar
• Le Doussal V, Tubiana-Hulin M, Friedman S. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 1989; 64: 1914–1921
   PubMed Web of Science ®Google Scholar
• Woosley J T. Measuring cell proliferation. Arch Pathol Lab Med 1991; 115: 555–557
   PubMed Web of Science ®Google Scholar
• Donhuijsen K, Schmidt U, Hirche H. Changes in mitotic rate and cell cycle fraction caused by delayed fixation. Hum Pathol 1990; 21: 709–714
   PubMed Web of Science ®Google Scholar
• Dooley W C, Roberts J, Allison D C. Acid Giemsa for rapid identification of mitotic cells. J Histochem Cytochem 1989; 37: 1553–1556
   PubMed Web of Science ®Google Scholar
• Busch C, Vasko J. Differential staining of mitoses in tissue sections and cultured cells by a modified methenamine-silver method. Lab Invest 1988; 59: 876–878
   PubMed Web of Science ®Google Scholar
• Baak J PA. Mitosis counting in tumors. Hum Pathol 1990; 21: 683–685
   PubMed Web of Science ®Google Scholar
• Russo J, Frederick J, Ownby H E. Predictors of recurrence and survival of patients with breast cancer. Am J Clin Pathol 1987; 88: 123–131
   PubMed Web of Science ®Google Scholar
• Lee A K, DeLellis R A, Silverman M L. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 1990; 8: 457–465
   Google Scholar
• Schmidt-Ullrich R, Wazer D E, Tercilla O. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989; 17: 733–738
   PubMed Web of Science ®Google Scholar
• Solin L J, Fowble B L, Schultz D J. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991; 21: 279–287
   PubMed Web of Science ®Google Scholar
• Trojani M. A Color Atlas of Breast Histopathology. Lippincott, Philadelphia 1991; 154–159
   Google Scholar
• Henson D E, Ries L, Friedman L S. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 1991; 68: 2142–2149
   PubMed Web of Science ®Google Scholar
• Elston C W, Ellis I O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histo-pathology 1991; 19: 403–410
   Google Scholar
• Rank F, Dombemowsky P, Jespersen N CB. Histologic malignancy grading of invasive ductal carcinoma. A regression analysis of prognostic factors in low-risk carcinoma from a mul-ticenter trial. Cancer 1987; 66: 1299–1305
   Google Scholar
• Henson D E. The histological grading of neoplasms. Arch Pathol Lab Med 1988; 112: 1091–1096
   PubMed Web of Science ®Google Scholar
• Fisher B, Redmond C, Fisher E R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project protocol B-06. J Clin Oncol 1988; 6: 1076–1087
   PubMed Web of Science ®Google Scholar
• Fisher E R, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP). Prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients. Cancer 1990; 65: 2121–2128
   PubMed Web of Science ®Google Scholar
• McGuire W L. Estrogen receptor versus nuclear grade as prognostic factors in axillary node negative breast cancer. J Clin Oncol 1988; 6: 1071–1072
   PubMed Web of Science ®Google Scholar